Market Cap 14.78B
Revenue (ttm) 8.33B
Net Income (ttm) 1.56B
EPS (ttm) N/A
PE Ratio 12.48
Forward PE 12.26
Profit Margin 18.69%
Debt to Equity Ratio 1.06
Volume 297,923
Avg Vol 1,304,638
Day's Range N/A - N/A
Shares Out 170.22M
Stochastic %K 71%
Beta 0.60
Analysts Sell
Price Target $93.13

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temp...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: (651) 733-1110
Address:
1750 Yankee Doodle Road, Eagan, United States
luckymox
luckymox Aug. 15 at 3:16 AM
$SOLV gotta retest that 80 level at some point in the next few months.
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 13 at 11:05 PM
$SOLV nice∆∆
0 · Reply
Boston7452
Boston7452 Aug. 13 at 6:07 PM
$SINT $SOLV $ZBH That market capture is 2 years or so. It should grow rapidly after that as no product suite could compete against IP that is antipathogenic, bioactive encouraging bone and tissue healing, reduces metallosis, Hospital HAI, and improves imagining in additon to the base products already established.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 6 at 2:47 AM
$MSI $SOLV $BLLN $HUBS $UWMC AFTER-HOURS MOVERS: Currently Higher After Earnings: - SiTime (SITM) up 34.1% - SoundHound (SOUN) up 22.0% - Aeva (AEVA) up 18.3% - Paycom (PAYC) up 14.4% - ZoomInfo (GTM) up 5.5% - Motorola Solutions (MSI) up 5.0% - Solventum (SOLV) up 2.9% Currently Lower After Earnings: - BillionToOne (BLLN) down 27.9% - ThredUp (TDUP) down 27.9% - HubSpot (HUBS) down 20.1% - UWM Holdings (UWMC) down 16.4% - AppLovin (APP) down 15.8% - Sunrun (RUN) down 12.7% - Western Digital (WDC) down 11.7% - Zillow (ZG) down 7.8% - CF Industries (CF) down 6.4% - Axon Enterprises (AXON) down 3.5%.
0 · Reply
luckymox
luckymox Aug. 5 at 9:50 PM
$SOLV whoa it hit 90! I’m shocked.
1 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 9:45 PM
https://www.marketbeat.com/earnings/reports/2026-8-5--stock-14/ $SOLV Solventum Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 8:24 PM
$SOLV Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.53 up 1.92% YoY • Reported revenue of $2.21B up 2.22% YoY • Solventum updated its full-year 2026 guidance, raising organic sales growth to +2.5% to +3.0%, increasing adjusted EPS to $7.10 to $7.20, and lifting free cash flow to $200M-$300M.
0 · Reply
JamesNelson422
JamesNelson422 Aug. 5 at 6:54 AM
$GIB $SOLV $GFL $QNT $DOC CGI expands IT consulting, Solventum focuses on healthcare innovation, GFL Environmental grows waste management, QNT remains execution-driven, and Healthpeak Properties benefits from healthcare real estate.
0 · Reply
Boston7452
Boston7452 Aug. 4 at 4:36 AM
$SOLV +$ZBH + Sint = Bioshield!
1 · Reply
HODLcoin
HODLcoin Aug. 3 at 9:16 PM
$SOLV buy this one
0 · Reply
Latest News on SOLV
Solventum price target raised to $101 from $94 at Wedbush

2026-08-06T12:49:41.000Z - 13 days ago

Solventum price target raised to $101 from $94 at Wedbush


Solventum price target raised to $100 from $90 at Stifel

2026-08-06T12:38:08.000Z - 13 days ago

Solventum price target raised to $100 from $90 at Stifel


Solventum price target raised to $101 from $95 at UBS

2026-08-06T11:57:13.000Z - 13 days ago

Solventum price target raised to $101 from $95 at UBS


Solventum price target raised to $84 from $81 at BMO Capital

2026-08-06T11:32:09.000Z - 13 days ago

Solventum price target raised to $84 from $81 at BMO Capital


Solventum price target raised to $113 from $100 at Mizuho

2026-08-06T11:25:55.000Z - 13 days ago

Solventum price target raised to $113 from $100 at Mizuho


Solventum price target raised to $102 from $93 at KeyBanc

2026-08-06T11:01:34.000Z - 13 days ago

Solventum price target raised to $102 from $93 at KeyBanc


Solventum price target raised to $95 from $91 at BTIG

2026-08-06T09:55:30.000Z - 13 days ago

Solventum price target raised to $95 from $91 at BTIG


Solventum Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Solventum Earnings Call Transcript: Q2 2026


Solventum Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Solventum Earnings release: Q2 2026


Solventum Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Solventum Slides: Q2 2026


Solventum Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Solventum Quarterly report: Q2 2026


Solventum Shareholder letter: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Solventum Shareholder letter: Q2 2026


Solventum reports Q2 adjusted EPS $2.55, consensus $1.91

2026-08-05T20:15:37.000Z - 13 days ago

Solventum reports Q2 adjusted EPS $2.55, consensus $1.91


Solventum Reports Second Quarter 2026 Financial Results

Aug 5, 2026, 4:12 PM EDT - 13 days ago

Solventum Reports Second Quarter 2026 Financial Results


Solventum assumed with Buy from Neutral at UBS

2026-07-28T12:07:22.000Z - 22 days ago

Solventum assumed with Buy from Neutral at UBS


Solventum assumed with Buy from Neutral at UBS

2026-07-28T10:51:17.000Z - 22 days ago

Solventum assumed with Buy from Neutral at UBS


Solventum price target raised to $91 from $89 at BTIG

2026-07-13T11:20:07.000Z - 5 weeks ago

Solventum price target raised to $91 from $89 at BTIG


Solventum initiated with a Market Perform at BMO Capital

2026-07-08T20:25:32.000Z - 5 weeks ago

Solventum initiated with a Market Perform at BMO Capital


Solventum management to meet with Piper Sandler

2026-06-10T19:45:09.000Z - 2 months ago

Solventum management to meet with Piper Sandler


Solventum Transcript: AGM 2026

May 15, 2026, 9:00 AM EDT - 3 months ago

Solventum Transcript: AGM 2026


Solventum Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Solventum Earnings Call Transcript: Q1 2026


Solventum Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Solventum Earnings release: Q1 2026


Solventum Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Solventum Slides: Q1 2026


Solventum Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Solventum Quarterly report: Q1 2026


Solventum Shareholder letter: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Solventum Shareholder letter: Q1 2026


Solventum Reports First Quarter 2026 Financial Results

May 5, 2026, 4:05 PM EDT - 3 months ago

Solventum Reports First Quarter 2026 Financial Results


Solventum Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Solventum Proxy statement: Proxy filing


Solventum Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Solventum Proxy statement: Proxy filing


Solventum to Participate in the 2026 KeyBanc Healthcare Forum

Mar 11, 2026, 4:05 PM EDT - 5 months ago

Solventum to Participate in the 2026 KeyBanc Healthcare Forum


Solventum Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Solventum Earnings Call Transcript: Q4 2025


Solventum Shareholder letter: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Solventum Shareholder letter: Q4 2025


Solventum Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Solventum Annual report: Q4 2025


Solventum Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Solventum Earnings release: Q4 2025


Solventum Slides: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Solventum Slides: Q4 2025


Solventum Completes Acquisition of Acera Surgical

Dec 23, 2025, 4:05 PM EST - 8 months ago

Solventum Completes Acquisition of Acera Surgical


Solventum Announces $1 Billion Share Repurchase Program

Nov 20, 2025, 9:00 AM EST - 9 months ago

Solventum Announces $1 Billion Share Repurchase Program


Solventum Announces Agreement to Acquire Acera Surgical

Nov 20, 2025, 9:00 AM EST - 9 months ago

Solventum Announces Agreement to Acquire Acera Surgical


Solventum Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 11:20 AM EST - 10 months ago

Solventum Transcript: Stifel 2025 Healthcare Conference


Solventum Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Solventum Earnings Call Transcript: Q3 2025


Solventum Shareholder letter: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Solventum Shareholder letter: Q3 2025


Solventum Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Solventum Quarterly report: Q3 2025


Solventum Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Solventum Earnings release: Q3 2025


Solventum Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Solventum Slides: Q3 2025


Solventum Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

Solventum Reports Third Quarter 2025 Financial Results


Solventum Appoints Heather Knight as Chief Commercial Officer

Oct 21, 2025, 5:00 PM EDT - 10 months ago

Solventum Appoints Heather Knight as Chief Commercial Officer


Solventum to Participate in Upcoming Investor Conferences

Aug 28, 2025, 4:05 PM EDT - 1 year ago

Solventum to Participate in Upcoming Investor Conferences


Solventum Announces $1.75 Billion Note Tender Offers

Aug 22, 2025, 8:19 AM EDT - 1 year ago

Solventum Announces $1.75 Billion Note Tender Offers


Solventum Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Solventum Earnings Call Transcript: Q2 2025


Solventum Shareholder letter: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Solventum Shareholder letter: Q2 2025


Solventum Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Solventum Quarterly report: Q2 2025


Solventum Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Solventum Earnings release: Q2 2025


Solventum Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Solventum Slides: Q2 2025


Solventum Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 1 year ago

Solventum Reports Second Quarter 2025 Financial Results


Solventum Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Solventum Earnings Call Transcript: Q1 2025


Solventum Shareholder letter: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Solventum Shareholder letter: Q1 2025


Solventum Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Solventum Quarterly report: Q1 2025


Solventum Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Solventum Earnings release: Q1 2025


Solventum Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Solventum Slides: Q1 2025


Solventum Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 1 year ago

Solventum Reports First Quarter 2025 Financial Results


Solventum Proxy statement: Proxy Filing

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Solventum Proxy statement: Proxy Filing


Solventum Proxy statement: Proxy Filing

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Solventum Proxy statement: Proxy Filing


Solventum Transcript: Investor Day 2025

Mar 20, 2025, 1:00 PM EDT - 1 year ago

Solventum Transcript: Investor Day 2025


Solventum Slides: FY 2025

Mar 20, 2025, 1:00 PM EDT - 1 year ago

Solventum Slides: FY 2025


Solventum Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Solventum Earnings Call Transcript: Q4 2024


Solventum Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Solventum Annual report: Q4 2024


Solventum Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Solventum Earnings release: Q4 2024


Solventum Slides: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Solventum Slides: Q4 2024


luckymox
luckymox Aug. 15 at 3:16 AM
$SOLV gotta retest that 80 level at some point in the next few months.
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 13 at 11:05 PM
$SOLV nice∆∆
0 · Reply
Boston7452
Boston7452 Aug. 13 at 6:07 PM
$SINT $SOLV $ZBH That market capture is 2 years or so. It should grow rapidly after that as no product suite could compete against IP that is antipathogenic, bioactive encouraging bone and tissue healing, reduces metallosis, Hospital HAI, and improves imagining in additon to the base products already established.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 6 at 2:47 AM
$MSI $SOLV $BLLN $HUBS $UWMC AFTER-HOURS MOVERS: Currently Higher After Earnings: - SiTime (SITM) up 34.1% - SoundHound (SOUN) up 22.0% - Aeva (AEVA) up 18.3% - Paycom (PAYC) up 14.4% - ZoomInfo (GTM) up 5.5% - Motorola Solutions (MSI) up 5.0% - Solventum (SOLV) up 2.9% Currently Lower After Earnings: - BillionToOne (BLLN) down 27.9% - ThredUp (TDUP) down 27.9% - HubSpot (HUBS) down 20.1% - UWM Holdings (UWMC) down 16.4% - AppLovin (APP) down 15.8% - Sunrun (RUN) down 12.7% - Western Digital (WDC) down 11.7% - Zillow (ZG) down 7.8% - CF Industries (CF) down 6.4% - Axon Enterprises (AXON) down 3.5%.
0 · Reply
luckymox
luckymox Aug. 5 at 9:50 PM
$SOLV whoa it hit 90! I’m shocked.
1 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 9:45 PM
https://www.marketbeat.com/earnings/reports/2026-8-5--stock-14/ $SOLV Solventum Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 8:24 PM
$SOLV Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.53 up 1.92% YoY • Reported revenue of $2.21B up 2.22% YoY • Solventum updated its full-year 2026 guidance, raising organic sales growth to +2.5% to +3.0%, increasing adjusted EPS to $7.10 to $7.20, and lifting free cash flow to $200M-$300M.
0 · Reply
JamesNelson422
JamesNelson422 Aug. 5 at 6:54 AM
$GIB $SOLV $GFL $QNT $DOC CGI expands IT consulting, Solventum focuses on healthcare innovation, GFL Environmental grows waste management, QNT remains execution-driven, and Healthpeak Properties benefits from healthcare real estate.
0 · Reply
Boston7452
Boston7452 Aug. 4 at 4:36 AM
$SOLV +$ZBH + Sint = Bioshield!
1 · Reply
HODLcoin
HODLcoin Aug. 3 at 9:16 PM
$SOLV buy this one
0 · Reply
luckymox
luckymox Jul. 29 at 5:39 PM
$SOLV what’s the recent catalyst causing this run?
2 · Reply
theoptionsplug
theoptionsplug Jul. 29 at 5:31 PM
$SOLV is having itself a day! However, running into resistance of ~$88, RSI is getting a bit high A break and hold of $88.25 can revisit $96!
0 · Reply
bigbulldaddy
bigbulldaddy Jul. 15 at 4:08 AM
$SOLV how is the bag holding going?
1 · Reply
UpgradeDowngrade
UpgradeDowngrade Jul. 10 at 2:24 PM
$SOLV BMO Capital Markets has altered their rating of "Market Perform" and target of "$81" see consensus outlook
0 · Reply
mhparvez
mhparvez Jun. 12 at 4:00 PM
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Jun. 10 at 12:54 AM
$S after reviewing Shao Yong hexagrams and speaking to a technologist-expert who’s also building a business delivering para-military troops 🥷 training (essentially mercenaries) for hire, which is a huge lucrative TAM (total addressable market) for small scale conflicts around the globe, I decided to include this to N-9. So N-9 has: 1). $VGNT, 2) $VSNT, 3) $SOLV, 4) BWXT, (5) VEEV, (6) $AMRZ (7) VC, (8) ADBE, and (9) S Part of the multiyear Funnel-to-Focus-to-Funnel strategy: A-8, S-6, F-5, N-9. Then definitely once you are so rich, keep your wealth in just ETF and enjoy life, for time and youth are more limited while money is so limitless out there. @LetsGoMets107 @mhparvez @WantedToRetireEarly @BIgBill374 @blancoBull @TaoistTrader
1 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Jun. 8 at 5:49 PM
$SOLV buy more.
0 · Reply
Doozio
Doozio Jun. 4 at 3:28 PM
Da HALO shall protect yo n da huckleberries $SOLV all da problems ONTO 🐒🍌🧠⏰♾️
1 · Reply
luckymox
luckymox Jun. 3 at 10:49 PM
$SOLV 8% down after hours???
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Jun. 1 at 4:29 PM
$SOLV this @mhparvez will move like $GEV
0 · Reply
Boston7452
Boston7452 May. 29 at 7:25 PM
$SINT $SOLV "We have several partnerships exploring opportunities in face masks, filters, wound care, and coatings" pg 9 10k
1 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar May. 27 at 5:21 AM
$SOLV for some reason a lot of V-stocks go up. If we read this ticker from right to left, it starts with V too. Jk but this is a very good stock in my Notorious 9 portfolio. It’s highly undervalued. Healthcare will be the next hype. It has a strong balance sheet and cash flow. This is greatly mispriced. Patience will be awarded. Accumulate before institutional buy. PT 300-500.
1 · Reply